IMAX Corporation (NYSE:IMAX – Get Free Report) CEO Richard Gelfond sold 100,000 shares of IMAX stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $53.23, for a total transaction of $5,323,000.00. Following the transaction, the chief executive officer directly owned 665,002 shares in the company, valued at approximately $35,398,056.46. This represents a 13.07% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
IMAX Trading Down 1.6%
Shares of IMAX stock traded down $0.84 during trading on Thursday, hitting $52.87. The company’s stock had a trading volume of 1,272,142 shares, compared to its average volume of 1,201,651. The company has a market cap of $2.90 billion, a PE ratio of 73.43, a P/E/G ratio of 1.67 and a beta of 0.38. The business has a fifty day moving average of $44.22 and a 200-day moving average of $39.93. IMAX Corporation has a 52 week low of $25.56 and a 52 week high of $54.50.
IMAX (NYSE:IMAX – Get Free Report) last posted its quarterly earnings data on Thursday, July 23rd. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.13. The business had revenue of $102.84 million for the quarter, compared to analysts’ expectations of $96.09 million. IMAX had a return on equity of 15.47% and a net margin of 9.84%.The business’s revenue was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.26 earnings per share. As a group, research analysts predict that IMAX Corporation will post 1.44 EPS for the current year.
Institutional Trading of IMAX
Trending Headlines about IMAX
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: “The Odyssey” is a major success for IMAX. The film has surpassed $1.29 billion globally and is being described as IMAX’s biggest release ever. Nearly 20,000 fans attended IMAX screenings at Odeon, while BFI IMAX reportedly named it the venue’s all-time box-office leader. The performance supports strong premium-format demand and IMAX’s revenue outlook. The Odyssey passes $1.29 billion and becomes IMAX’s biggest release ever
- Positive Sentiment: Demand for “Dune: Part Three” is exceptionally strong. Early 70mm IMAX showings are nearly sold out, presales reportedly overwhelmed booking websites, and scarce tickets are being resold at steep prices. This points to robust upcoming attendance, pricing power and continued interest in IMAX’s large-format experience. Early IMAX 70mm Dune showings nearly sell out
- Positive Sentiment: Analyst support remains constructive. Rosenblatt Securities reaffirmed its “buy” rating and set a $60 price target, implying additional upside from the cited market level. Rosenblatt Securities rating
- Neutral Sentiment: Some 70mm venues experienced projector or mechanical issues during “The Odyssey,” highlighting the limited availability and operational complexity of legacy film projection, although these reports appear localized. San Antonio’s 70mm IMAX projector
- Negative Sentiment: The immediate pressure appears more valuation- and momentum-related than fundamental: IMAX trades near its yearly high after a substantial advance, while its high earnings multiple leaves less room for disappointment. Ticket scarcity and scalping also create publicity risks if consumers cannot access screenings.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. B. Riley Financial boosted their price objective on IMAX from $48.00 to $52.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Seaport Research Partners reaffirmed a “buy” rating and set a $50.00 target price on shares of IMAX in a report on Wednesday, June 24th. Wall Street Zen upgraded IMAX from a “hold” rating to a “buy” rating in a research report on Saturday, July 25th. The Goldman Sachs Group reissued a “neutral” rating and issued a $42.00 price target on shares of IMAX in a report on Thursday, July 23rd. Finally, Rosenblatt Securities restated a “buy” rating and issued a $60.00 price objective on shares of IMAX in a research report on Wednesday. Ten equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $51.55.
Check Out Our Latest Stock Report on IMAX
About IMAX
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Featured Stories
- Five stocks we like better than IMAX
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
